Market Overview:
The global anti neurofilament L antibody market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of neurodegenerative diseases, rising demand for monoclonal antibodies, and technological advancements in the field of antibody production. Based on type, the global anti neurofilament L antibody market is segmented into mouse anti neurofilament L antibody, rabbit anti neurofilament L antibody, and others. The mouse anti neurofilament L antibody segment is expected to account for the largest share of the global market in 2018. This segment is projected to grow at a CAGR of 8% during the forecast period from 2018 to 2030. This growth can be attributed to factors such as rising demand for monoclonal antibodies and technological advancements in this area. Based on application, the globalanti-neurofiament l Antibody Marketis divided into academic and research institutes; pharma and biotech companies; contract research organizations (CROs); hospitals & clinics; diagnostic centers; other end users (such as veterinary laboratories).
Product Definition:
Neurofilament proteins are major structural components of nerve cells. They can be used to help diagnose certain neurological conditions. Anti-neurofilament antibodies are used to detect and measure levels of these proteins in the blood or cerebrospinal fluid.
Mouse Anti Neurofilament L Antibody:
The primary function of anti neurofilament l antibody is to identify and measure the amount of NF light chain in a sample. The test can be performed on any type of blood or plasma, but it is most commonly used for detecting patients with multiple sclerosis, as this disease causes an increase in antibodies that target the myelin sheath around nerve fibers.
Rabbit Anti Neurofilament L Antibody:
Rabbit anti neurofilament L antibody is used in the detection of neurofilaments. Neurofilaments are made up of a protein called NF200 and this protein has two binding sites for the antibody which allows it to bind to both, NF200 and myelin. The test is carried out by using an enzyme linked immunosorbent assay (ELISA).
Application Insights:
The academic and research Institutes segment held the largest share of the global market in 2017. This is attributed to growing government support for R&D activities and increasing number of academic institutions focusing on nervous system disorders. For instance, as per the statistics published by U.S National Library of Medicine National Institute of Health in 2018, around 1,000 neurological papers are published every year in India which is a huge potential market for pharmaceutical companies developing anti neurofilament l antibody drugs.
Pharma and biotech companies are also anticipated to witness lucrative growth over the forecast period due to rising incidence rates of neurodegenerative diseases such as Alzheimer¢â‚¬â„¢s disease, Parkinson¢â‚¬â„¢s disease etc., across all age groups worldwide which has created a significant need for new drug development against NF-L Antibodies.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, favorable reimbursement policies, and increasing prevalence of neurodegenerative diseases are some factors responsible for this dominance. In addition, the availability of skilled professionals and improvement in healthcare infrastructure is expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to an increase in biotechnology companies investing in this region along with a rise in government funding for R&D activities pertaining neurodegenerative disorders. Moreover, improving healthcare facilities due to rising disposable income will also boost regional market development during the estimated time span from 2018 to 2030 ( ).
In addition, growing medical tourism industry can also be attributed as a major factor contributing toward increased demand for anti NF1 antibodies within Asia Pacific region ( ).
Growth Factors:
- Increasing incidence of neurodegenerative diseases: The global prevalence of neurodegenerative diseases is increasing rapidly. This is mainly due to the aging population and the increased life expectancy. As a result, there is an increased demand for treatments for these conditions, including anti-neurofilament antibodies.
- Growing awareness about neurodegenerative diseases: There is growing awareness among people about the symptoms and potential treatments for neurodegenerative diseases. This is driving demand for anti-neurofilament antibodies as well as other therapies for these conditions.
- Advances in antibody technology: The development of new and more effective antibody technologies has helped to improve the efficacy of anti-neurofilament antibodies in treating neurodegenerative diseases. This has led to an increase in their use by physicians worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Anti Neurofilament L Antibody Market Research Report
By Type
Mouse Anti Neurofilament L Antibody, Rabbit Anti Neurofilament L Antibody, Others
By Application
Academic and Research Institutes, Pharma and Biotech Companies, Others
By Companies
Merck, BioLegend, Cell Signaling Technology, Rockland Immunochemicals, Bio-Rad Laboratories, EnCor Biotechnology
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
169
Number of Tables & Figures
119
Customization Available
Yes, the report can be customized as per your need.
Global Anti Neurofilament L Antibody Market Report Segments:
The global Anti Neurofilament L Antibody market is segmented on the basis of:
Types
Mouse Anti Neurofilament L Antibody, Rabbit Anti Neurofilament L Antibody, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Academic and Research Institutes, Pharma and Biotech Companies, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck
- BioLegend
- Cell Signaling Technology
- Rockland Immunochemicals
- Bio-Rad Laboratories
- EnCor Biotechnology
Highlights of The Anti Neurofilament L Antibody Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Mouse Anti Neurofilament L Antibody
- Rabbit Anti Neurofilament L Antibody
- Others
- By Application:
- Academic and Research Institutes
- Pharma and Biotech Companies
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Anti Neurofilament L Antibody Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Anti Neurofilament L Antibody is a type of antibody that targets and destroys the proteins found in neurofilaments. Neurofilaments are important components of the brain and spinal cord, and can be damaged by diseases or injuries. Anti-neurofilament L antibodies may help to improve symptoms related to these conditions.
Some of the key players operating in the anti neurofilament l antibody market are Merck, BioLegend, Cell Signaling Technology, Rockland Immunochemicals, Bio-Rad Laboratories, EnCor Biotechnology.
The anti neurofilament l antibody market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Anti Neurofilament L Antibody Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Anti Neurofilament L Antibody Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Anti Neurofilament L Antibody Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Anti Neurofilament L Antibody Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Anti Neurofilament L Antibody Market Size & Forecast, 2018-2028
4.5.1 Anti Neurofilament L Antibody Market Size and Y-o-Y Growth
4.5.2 Anti Neurofilament L Antibody Market Absolute $ Opportunity
Chapter 5 Global Anti Neurofilament L Antibody Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Anti Neurofilament L Antibody Market Size Forecast by Type
5.2.1 Mouse Anti Neurofilament L Antibody
5.2.2 Rabbit Anti Neurofilament L Antibody
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Anti Neurofilament L Antibody Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Anti Neurofilament L Antibody Market Size Forecast by Applications
6.2.1 Academic and Research Institutes
6.2.2 Pharma and Biotech Companies
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Anti Neurofilament L Antibody Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Anti Neurofilament L Antibody Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Anti Neurofilament L Antibody Analysis and Forecast
9.1 Introduction
9.2 North America Anti Neurofilament L Antibody Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Anti Neurofilament L Antibody Market Size Forecast by Type
9.6.1 Mouse Anti Neurofilament L Antibody
9.6.2 Rabbit Anti Neurofilament L Antibody
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Anti Neurofilament L Antibody Market Size Forecast by Applications
9.10.1 Academic and Research Institutes
9.10.2 Pharma and Biotech Companies
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Anti Neurofilament L Antibody Analysis and Forecast
10.1 Introduction
10.2 Europe Anti Neurofilament L Antibody Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Anti Neurofilament L Antibody Market Size Forecast by Type
10.6.1 Mouse Anti Neurofilament L Antibody
10.6.2 Rabbit Anti Neurofilament L Antibody
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Anti Neurofilament L Antibody Market Size Forecast by Applications
10.10.1 Academic and Research Institutes
10.10.2 Pharma and Biotech Companies
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Anti Neurofilament L Antibody Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Anti Neurofilament L Antibody Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Anti Neurofilament L Antibody Market Size Forecast by Type
11.6.1 Mouse Anti Neurofilament L Antibody
11.6.2 Rabbit Anti Neurofilament L Antibody
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Anti Neurofilament L Antibody Market Size Forecast by Applications
11.10.1 Academic and Research Institutes
11.10.2 Pharma and Biotech Companies
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Anti Neurofilament L Antibody Analysis and Forecast
12.1 Introduction
12.2 Latin America Anti Neurofilament L Antibody Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Anti Neurofilament L Antibody Market Size Forecast by Type
12.6.1 Mouse Anti Neurofilament L Antibody
12.6.2 Rabbit Anti Neurofilament L Antibody
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Anti Neurofilament L Antibody Market Size Forecast by Applications
12.10.1 Academic and Research Institutes
12.10.2 Pharma and Biotech Companies
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Anti Neurofilament L Antibody Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Anti Neurofilament L Antibody Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Anti Neurofilament L Antibody Market Size Forecast by Type
13.6.1 Mouse Anti Neurofilament L Antibody
13.6.2 Rabbit Anti Neurofilament L Antibody
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Anti Neurofilament L Antibody Market Size Forecast by Applications
13.10.1 Academic and Research Institutes
13.10.2 Pharma and Biotech Companies
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Anti Neurofilament L Antibody Market: Competitive Dashboard
14.2 Global Anti Neurofilament L Antibody Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck
14.3.2 BioLegend
14.3.3 Cell Signaling Technology
14.3.4 Rockland Immunochemicals
14.3.5 Bio-Rad Laboratories
14.3.6 EnCor Biotechnology
